Dp Derm is the US distributor for the world-leading FDA-cleared microneedling technology, the Dp4, as well as its accompanying line of protocol products, DP Dermaceuticals. Formulated to deliver superior results in clinical microneedling treatments, Dp Dermaceuticals have an extended purpose in supporting medical skin resurfacing treatments outside of the clinic as well. While as a company we mainly work directly with aesthetic professionals, our products are designed to support the full patient journey, from the clinic and into the home. Our goal is to deliver the most effective protocols that lead to the best possible results, and our focus is to empower both the practitioner and the patient through superior service and education. Our core industries include Consumer Goods, E-Commerce, and Health Care, with our headquarters based in the United States. As of now, there is no record of the last investment and last investment investors.
There is no investment information
No recent news or press coverage available for Dp Derm.